OBJECTIVE: To validate and apply a method for independent assessment of insulin secretion and insulin sensitivity (S(I)) during the same test; that is, an intravenous glucose tolerance test followed by a euglycemic-hyperinsulinemic clamp, also called the Botnia clamp. This test was then applied to nondiabetic subjects with (FH+) and without (FH-) a first-degree family history of diabetes. RESEARCH DESIGN AND METHODS: The Botnia clamp measures the first-phase insulin response (FPIR) to 0.3g/kg glucose i.v. and insulin sensitivity (M-value) from a 2-h euglycemic clamp begun 60 min after the glucose bolus. The M-value obtained during the Botnia clamp was compared with M-values obtained during a regular euglycemic clamp without prior glucose bolus. Repeated tests were performed in random order in subjects with normal and abnormal glucose tolerance. Finally, the test was applied to subjects with and without a family history of type 2 diabetes. RESULTS: S(I) and insulin secretion from this test showed a high degree of reproducibility, and the M-value obtained with the Botnia clamp correlated strongly with the M-value from a euglycemic clamp without prior glucose bolus (r = 0.953, P < 0.005). FH+ subjects showed decreased S(I) (P = 0.02), but similar FPIR, compared with FH- subjects. However, insulin secretion adjusted for the degree of insulin resistance was significantly impaired (P = 0.04). CONCLUSIONS: In conclusion, the Botnia clamp provides reliable and independent measures of S(I) and beta-cell function during the same test. As illustrated above, knowledge of the degree of S(I) is mandatory when presenting data on insulin secretion.
OBJECTIVE: To validate and apply a method for independent assessment of insulin secretion and insulin sensitivity (S(I)) during the same test; that is, an intravenous glucose tolerance test followed by a euglycemic-hyperinsulinemic clamp, also called the Botnia clamp. This test was then applied to nondiabetic subjects with (FH+) and without (FH-) a first-degree family history of diabetes. RESEARCH DESIGN AND METHODS: The Botnia clamp measures the first-phase insulin response (FPIR) to 0.3g/kg glucose i.v. and insulin sensitivity (M-value) from a 2-h euglycemic clamp begun 60 min after the glucose bolus. The M-value obtained during the Botnia clamp was compared with M-values obtained during a regular euglycemic clamp without prior glucose bolus. Repeated tests were performed in random order in subjects with normal and abnormal glucose tolerance. Finally, the test was applied to subjects with and without a family history of type 2 diabetes. RESULTS: S(I) and insulin secretion from this test showed a high degree of reproducibility, and the M-value obtained with the Botnia clamp correlated strongly with the M-value from a euglycemic clamp without prior glucose bolus (r = 0.953, P < 0.005). FH+ subjects showed decreased S(I) (P = 0.02), but similar FPIR, compared with FH- subjects. However, insulin secretion adjusted for the degree of insulin resistance was significantly impaired (P = 0.04). CONCLUSIONS: In conclusion, the Botnia clamp provides reliable and independent measures of S(I) and beta-cell function during the same test. As illustrated above, knowledge of the degree of S(I) is mandatory when presenting data on insulin secretion.
Authors: Sabine Kahl; Bettina Nowotny; Simon Piepel; Peter J Nowotny; Klaus Strassburger; Christian Herder; Giovanni Pacini; Michael Roden Journal: Diabetologia Date: 2014-07-22 Impact factor: 10.122
Authors: Hannah J Burden; Shannon Adams; Braydon Kulatea; Morag Wright-McNaughton; Danielle Sword; Jennifer J Ormsbee; Conor Watene-O'Sullivan; Tony R Merriman; Jennifer L Knopp; J Geoffrey Chase; Jeremy D Krebs; Rosemary M Hall; Lindsay D Plank; Rinki Murphy; Peter R Shepherd; Troy L Merry Journal: Diabetologia Date: 2021-08-21 Impact factor: 10.122
Authors: S A Schäfer; K Müssig; H Staiger; F Machicao; N Stefan; B Gallwitz; H U Häring; A Fritsche Journal: Diabetologia Date: 2009-03-28 Impact factor: 10.122
Authors: M Laakso; J Zilinskaite; T Hansen; T Welløv Boesgaard; M Vänttinen; A Stancáková; P-A Jansson; F Pellmé; J J Holst; T Kuulasmaa; M L Hribal; G Sesti; N Stefan; A Fritsche; H Häring; O Pedersen; U Smith Journal: Diabetologia Date: 2007-12-14 Impact factor: 10.122
Authors: Kieren J Mather; Ashley H Tjaden; Adam Hoehn; Kristen J Nadeau; Thomas A Buchanan; Steven E Kahn; Silva A Arslanian; Sonia Caprio; Karen M Atkinson; Melanie Cree-Green; Kristina M Utzschneider; Sharon L Edelstein Journal: Am J Physiol Endocrinol Metab Date: 2021-03-01 Impact factor: 4.310
Authors: Martin Heni; Caroline Ketterer; Robert Wagner; Katarzyna Linder; Anja Böhm; Silke A Herzberg-Schäfer; Fausto Machicao; Klaus-Peter Knoch; Andreas Fritsche; Harald Staiger; Hans-Ulrich Häring; Michele Solimena Journal: PLoS One Date: 2012-10-15 Impact factor: 3.240
Authors: Harald Staiger; Anja Böhm; Mika Scheler; Lucia Berti; Jürgen Machann; Fritz Schick; Fausto Machicao; Andreas Fritsche; Norbert Stefan; Cora Weigert; Anna Krook; Hans-Ulrich Häring; Martin Hrabě de Angelis Journal: PLoS One Date: 2013-04-25 Impact factor: 3.240